E. Ohman J or Asset Management AB Has $26.32 Million Stock Position in Surgery Partners, Inc. (NASDAQ:SGRY)

E. Ohman J or Asset Management AB increased its stake in Surgery Partners, Inc. (NASDAQ:SGRY) by 40.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,243,111 shares of the company’s stock after buying an additional 357,023 shares during the quarter. E. Ohman J or Asset Management AB owned approximately 0.98% of Surgery Partners worth $26,317,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. KBC Group NV lifted its stake in Surgery Partners by 31.8% in the third quarter. KBC Group NV now owns 2,385 shares of the company’s stock valued at $77,000 after acquiring an additional 576 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. lifted its stake in Surgery Partners by 747.6% in the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company’s stock valued at $124,000 after purchasing an additional 3,379 shares during the last quarter. Creative Planning bought a new position in Surgery Partners during the third quarter worth about $258,000. Versor Investments LP acquired a new position in Surgery Partners during the third quarter worth approximately $271,000. Finally, Inspire Investing LLC raised its stake in Surgery Partners by 47.5% in the fourth quarter. Inspire Investing LLC now owns 19,034 shares of the company’s stock valued at $403,000 after buying an additional 6,131 shares during the period.

Analyst Ratings Changes

SGRY has been the subject of several research analyst reports. KeyCorp assumed coverage on Surgery Partners in a research note on Friday, October 11th. They set a “sector weight” rating for the company. Royal Bank of Canada reduced their target price on shares of Surgery Partners from $49.00 to $35.00 and set an “outperform” rating for the company in a report on Wednesday, November 20th. Macquarie reiterated an “outperform” rating and issued a $34.00 price target on shares of Surgery Partners in a research note on Tuesday, November 19th. Bank of America began coverage on shares of Surgery Partners in a research report on Monday, December 16th. They set a “buy” rating and a $30.00 price objective for the company. Finally, UBS Group began coverage on Surgery Partners in a research report on Monday, October 14th. They issued a “buy” rating and a $38.00 target price on the stock. One investment analyst has rated the stock with a sell rating, three have given a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat.com, Surgery Partners currently has a consensus rating of “Moderate Buy” and a consensus target price of $36.56.

Surgery Partners Price Performance

Shares of NASDAQ SGRY opened at $25.30 on Tuesday. The business has a fifty day moving average price of $21.61 and a two-hundred day moving average price of $27.05. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.99. Surgery Partners, Inc. has a fifty-two week low of $19.50 and a fifty-two week high of $35.29.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings data on Tuesday, November 12th. The company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.25 by ($0.06). Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The firm had revenue of $770.40 million for the quarter, compared to the consensus estimate of $768.99 million. During the same period in the prior year, the company earned $0.15 EPS. The company’s revenue for the quarter was up 14.3% compared to the same quarter last year. On average, equities research analysts anticipate that Surgery Partners, Inc. will post 0.71 EPS for the current year.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.